Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Change in Account Payables (2016 - 2025)

Icu Medical (ICUI) has disclosed Change in Account Payables for 17 consecutive years, with -$16.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Account Payables fell 90.88% year-over-year to -$16.3 million, compared with a TTM value of $7.0 million through Dec 2025, down 44.15%, and an annual FY2025 reading of $7.0 million, down 44.15% over the prior year.
  • Change in Account Payables was -$16.3 million for Q4 2025 at Icu Medical, down from $8.9 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $32.1 million in Q1 2025 and bottomed at -$27.5 million in Q1 2023.
  • Average Change in Account Payables over 5 years is -$447650.0, with a median of $2.5 million recorded in 2021.
  • The sharpest move saw Change in Account Payables skyrocketed 708.96% in 2022, then crashed 831.15% in 2023.
  • Year by year, Change in Account Payables stood at $12.7 million in 2021, then plummeted by 44.51% to $7.1 million in 2022, then tumbled by 146.07% to -$3.3 million in 2023, then tumbled by 163.07% to -$8.6 million in 2024, then tumbled by 90.88% to -$16.3 million in 2025.
  • Business Quant data shows Change in Account Payables for ICUI at -$16.3 million in Q4 2025, $8.9 million in Q3 2025, and -$17.7 million in Q2 2025.